1. What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?

   • Robert Peter Gale
   • Jane Apperley

   Chronic Myeloid Leukemias (G Saglio, Section Editor) 19 December 2019 Pages: 477 - 479

2. Early Management of CML

   • Naranie Shanmuganathan
   • Timothy P. Hughes

   Chronic Myeloid Leukemias (G Saglio, Section Editor) 07 November 2019 Pages: 480 - 491

   

3. Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia

   • Florence Rabian
   • Etienne Lengline
   • Delphine Rea

   Chronic Myeloid Leukemias (G Saglio, Section Editor) Open access 23 November 2019 Pages: 492 - 500

   

4. The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?

   • Naranie Shanmuganathan
   • Susan Branford

   Chronic Myeloid Leukemias (G Saglio, Section Editor) 07 November 2019 Pages: 501 - 506

5. Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients with Chronic Myeloid Leukaemia in Clinical Practice

   • Richard E. Clark

   Chronic Myeloid Leukemias (G Saglio, Section Editor) Open access 07 November 2019 Pages: 507 - 514

   

6. Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

   • Minas P. Economides
   • David Rizzieri
   • Naveen Pemmaraju

   Acute Myeloid Leukemias (H Erba, Section Editor) 18 December 2019 Pages: 515 - 522

7. Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: a Young International Society of Geriatric Oncology Review Paper

   • Kah Poh Loh
   • Maya Abdallah
   • Heidi D. Klepin

   Acute Myeloid Leukemias (H Erba, Section Editor) 27 November 2019 Pages: 523 - 535

   

8. The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS)

   • David P. Steensma

   Myelodysplastic Syndromes (M Savona, Section Editor) 07 November 2019 Pages: 536 - 542

9. Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO

   • Andrew T. Kuykendall
   • Eric Padron

   Myelodysplastic Syndromes (M Savona, Section Editor) 27 November 2019 Pages: 543 - 549

   

10. Mutation-Driven Therapy in MDS

    • David M. Swoboda
    • David A. Sallman

    Myelodysplastic Syndromes (M Savona, Section Editor) 23 November 2019 Pages: 550 - 560

11. Driving the CAR to the Bone Marrow Transplant Program

    • Hema Dave
    • Lauren Jerkins
    • David Jacobsohn

    CART and Immunotherapy (M Ruella and P Hanley, Section Editors) 23 October 2019 Pages: 561 - 569

    

12. Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders

    • Geoffrey Shouse
    • Liana Nikolaenko

    T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor) 18 November 2019 Pages: 570 - 576